← Back to Search
Disulfiram Is An Inhibitor Of Human Purified Monoacylglycerol Lipase, The Enzyme Regulating 2‐Arachidonoylglycerol Signaling
G. Labar, C. Bauvois, G. Muccioli, J. Wouters, D. Lambert
Published 2007 · Medicine, Chemistry
Download PDFAnalyze on Scholarcy
Monoacylglycerol lipase (MAGL) is a key enzyme responsible for the termination of endocannabinoid signaling. Its crucial role in 2‐arachidonoylglycerol (2‐AG) metabolism, together with the numerous pharmacological properties mediated by this endocannabinoid, emphasize the interest in MAGL as therapeutic target, along with the need to design potent and selective inhibitors. Meanwhile, the complexity of 2‐AG degradation pathways underscores the need to use a purified source of enzyme in evaluation studies of new inhibitors. We report here the first heterologous expression and purification of human MAGL. A highly pure protein was obtained and allowed us to measure the affinity of several MAGL inhibitors for the human enzyme. Importantly, disulfiram (tetraethylthiuram disulfide), a compound used to treat alcoholism, and other disulfide‐containing compounds were shown to inhibit MAGL with good potency, likely through an interaction with cysteine residues.
This paper references
N-cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase.
K. Tsuboi (2004)
A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer cells.
K. Nithipatikom (2005)
Lack of selectivity of URB602 for 2‐oleoylglycerol compared to anandamide hydrolysis in vitro
S. Vandevoorde (2007)
An endocannabinoid mechanism for stress-induced analgesia
A. Hohmann (2005)
Structure and function of fatty acid amide hydrolase.
M. K. McKinney (2005)
A second endogenous cannabinoid that modulates long-term potentiation
N. Stella (1997)
S-methyl N,N-diethylthiocarbamate sulfone, a potential metabolite of disulfiram and potent inhibitor of low Km mitochondrial aldehyde dehydrogenase.
D. Mays (1995)
2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.
T. Sugiura (1995)
Protein Expression Purif
M. Karlsson (2000)
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
B. Cravatt (1996)
Identification of a Novel Endocannabinoid-Hydrolyzing Enzyme Expressed by Microglial Cells
G. Muccioli (2007)
Isolation and structure of a brain constituent that binds to the cannabinoid receptor.
W. Devane (1992)
RNA Interference Suggests a Primary Role for Monoacylglycerol Lipase in the Degradation of the Endocannabinoid 2-Arachidonoylglycerol
T. Dinh (2004)
Brain monoglyceride lipase participating in endocannabinoid inactivation
T. V. Dinh (2002)
Protective activation of the endocannabinoid system during ischemia in dopamine neurons
M. Melis (2006)
Endocannabinoids and vascular function.
C. Hillard (2000)
cDNA Cloning, Tissue Distribution, and Identification of the Catalytic Triad of Monoglyceride Lipase
M. Karlsson (1997)
Molecular Characterization of N-Acylethanolamine-hydrolyzing Acid Amidase, a Novel Member of the Choloylglycine Hydrolase Family with Structural and Functional Similarity to Acid Ceramidase*
K. Tsuboi (2005)
Expression, purification, and characterization of histidine-tagged mouse monoglyceride lipase from baculovirus-infected insect cells.
M. Karlsson (2000)
Disulfiram metabolism as a requirement for the inhibition of rat liver mitochondrial low Km aldehyde dehydrogenase.
J. J. Yourick (1991)
2‐Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL‐1 human eosinophilic leukemia cells and human peripheral blood eosinophils
S. Oka (2004)
Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand.
T. Sugiura (2006)
Suppression of Nerve Growth Factor Trk Receptors and Prolactin Receptors by Endocannabinoids Leads to Inhibition of Human Breast and Prostate Cancer Cell Proliferation1.
D. Melck (2000)
Mechanism of inactivation of sheep liver cytoplasmic aldehyde dehydrogenase by disulfiram.
T. Kitson (1983)
Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells.
T. Bisogno (1997)
Purification and some properties of a monoacylglycerol-hydrolyzing enzyme of rat adipose tissue.
H. Tornqvist (1976)
A Second Fatty Acid Amide Hydrolase with Variable Distribution among Placental Mammals*
B. Q. Wei (2006)
URB754 has no effect on the hydrolysis or signaling capacity of 2-AG in the rat brain.
S. Saario (2006)
Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes.
S. Saario (2005)
Erratum: Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus (Nature Neuroscience (2005) 8, (1139-1141))
J. Makara (2007)
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
R. Wilson (2001)
Role of disulfiram in the in vitro inhibition of rat liver mitochondrial aldehyde dehydrogenase.
M. L. Shen (2000)
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.
R. Mechoulam (1995)
2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces rapid actin polymerization in HL-60 cells differentiated into macrophage-like cells.
Maiko Gokoh (2005)
Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2‐arachidonoylglycerol
N. Ghafouri (2004)
Specific Alterations of Extracellular Endocannabinoid Levels in the Nucleus Accumbens by Ethanol, Heroin, and Cocaine Self-Administration
S. Caille (2007)
Subcellular localization and some properties of monoacylglycerol lipase in rat adipocytes.
T. Sakurada (1981)
This paper is referenced by
Set-Up and Validation of a High Throughput Screening Method for Human Monoacylglycerol Lipase (MAGL) Based on a New Red Fluorescent Probe
Matteo Miceli (2019)
Measuring Endocannabinoid Hydrolysis: Refining our Tools and Understanding
William R. Marrs (2009)
The endocannabinoid 2‐arachidonoylglycerol activates human platelets through non‐CB1/CB2 receptors
S. Baldassarri (2008)
Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor
Ryan M Wyatt (2020)
Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors.
Anna Minkkilae (2010)
beta-Lactams derived from a carbapenem chiron are selective inhibitors of human fatty acid amide hydrolase versus human monoacylglycerol lipase.
Marion Feledziak (2009)
Effects of pesticide chemicals on the activity of metabolic enzymes: focus on thiocarbamates
Cécile Mathieu (2015)
Development and characterization of endocannabinoid hydrolases FAAH and MAGL inhibitors bearing a benzotriazol-1-yl carboxamide scaffold.
L. Morera (2012)
An unprecedented reversible mode of action of β-lactams for the inhibition of human fatty acid amide hydrolase (hFAAH).
Marion Feledziak (2013)
3‐Heterocycle‐Phenyl N‐Alkylcarbamates as FAAH Inhibitors: Design, Synthesis and 3D‐QSAR Studies
Heikki Käsnänen (2010)
Kavalactones and the endocannabinoid system: the plant-derived yangonin is a novel CB₁ receptor ligand.
A. Ligresti (2012)
A review on the monoacylglycerol lipase: at the interface between fat and endocannabinoid signalling.
G. Labar (2010)
Crystal Structure of the Human Monoacylglycerol Lipase, a Key Actor in Endocannabinoid Signaling
G. Labar (2010)
Monoacylglycerol lipase (MAGL) as a promising therapeutic target.
Ana Gil-Ordóñez (2018)
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders
H. Deng (2020)
(S)-1-(Pent-4′-enoyl)-4-(hydroxymethyl)-azetidin-2-one derivatives as inhibitors of human fatty acid amide hydrolase (hFAAH): synthesis, biological evaluation and molecular modelling
J. Caruano (2014)
Screening and Characterization of Human Monoglyceride Lipase Active Site Inhibitors Using Orthogonal Binding and Functional Assays
J. C. Clemente (2012)
CAY10499, a Novel Monoglyceride Lipase Inhibitor Evidenced by an Expeditious MGL Assay
G. Muccioli (2008)
Dithiocarbamates as Precursors in Organic Chemistry; Synthesis and Uses
E. Hassan (2014)
Insight into the Willgerodt-Kindler Reaction of ω-Haloacetophenone Derivatives: Mechanistic Implication
Urbain C. Kasséhin (2014)
1,3,4-Oxadiazol-2-ones as fatty-acid amide hydrolase and monoacylglycerol lipase inhibitors: Synthesis, in vitro evaluation and insight into potency and selectivity determinants by molecular modelling.
Heikki Käsnänen (2013)
Application of Molecular Modelling studies to the search of novel approaches for neuroprotection and stem cells applications
Laura Scalvini (2016)
Monoglyceride lipase: Structure and inhibitors.
Laura Scalvini (2016)
Chemistry around imidazopyrazine and ibuprofen: discovery of novel fatty acid amide hydrolase (FAAH) inhibitors.
Frédéric De Wael (2010)
Human α/β Hydrolase Domain Containing 10 (ABHD10) Is Responsible Enzyme for Deglucuronidation of Mycophenolic Acid Acyl-glucuronide in Liver*
Atsushi Iwamura (2012)
Loratadine analogues as MAGL inhibitors.
Jayendra Z Patel (2015)
Human Arylacetamide Deacetylase Is a Principal Enzyme in Flutamide Hydrolysis
Akinobu Watanabe (2009)
Bis(dialkylaminethiocarbonyl)disulfides as potent and selective monoglyceride lipase inhibitors.
C. N. Kapanda (2009)
Endocannabinoid biosynthesis and inactivation, from simple to complex.
G. Muccioli (2010)
Synthesis and pharmacological evaluation of 2,4-dinitroaryldithiocarbamate derivatives as novel monoacylglycerol lipase inhibitors.
C. N. Kapanda (2012)
3-Alkenyl-2-azetidinones as fatty acid amide hydrolase inhibitors.
A. Urbach (2008)
Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol.
N. Ueda (2011)See more